
Processa Pharmaceuticals, Inc.
PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2013-08-0817:19 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001393905-13-000403 |
| 2013-07-1017:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001393905-13-000342 |
| 2013-07-0913:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001393905-13-000339 |
| 2013-06-2115:58 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001393905-13-000318 |
| 2013-05-2315:11 ET | S-1/A | Registration statement, amended | 0001393905-13-000286 |
| 2013-05-1517:57 ET | S-1/A | Registration statement, amended | 0001282869-13-000003 |
| 2013-04-1118:56 ET | S-1/A | Registration statement, amended | 0001393905-13-000154 |
| 2013-03-1416:11 ET | S-1/A | Registration statement, amended | 0001533743-13-000002 |
| 2013-01-1116:39 ET | S-1/A | Registration statement, amended | 0001193125-13-010805 |
| 2012-11-1416:47 ET | S-1 | Registration statement | 0001533743-12-000006 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.